Investing Ideas
/
Vietnamese Healthcare Undervalued over 20% based on DCF

Vietnamese Healthcare Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

American Vietnamese Biotech Incorporation

Market Cap: ₫196.7b

Engages in the manufacturing and trading of medical diagnostic biological products in Vietnam.

AMV

₫1,500.00

-6.3%

n/a